• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 30 Oct 2025

3Q:25 EPS Just Shy Of Our Forecast; Fine-Tuned EPS Estimates Still Imply Additional Gains As Management Looks To Further Reduce Costs; Dividend Raised Again; Maintain $17 Price Target


Pitney Bowes (PBI:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Anthony C. Lebiedzinski

    • 10 pages


 

Mainly reflecting lower than anticipated sales in its Presort Services segment, PBI delivered total revenue of $459.7 million in 3Q:25, which trailed our forecast of $467.4 million. With a lower than expected EBIT, partly offset by share buybacks, EPS of $0.31 in 3Q:25 was a penny below our forecast. PBI now expects to be at the lower end of its previous forecast for revenue and EBIT and around the midpoint of its previous guidance for EPS in 2025. As we fine tune our quarterly assumptions, we trim our 2025 EPS estimate by $0.01 to $1.29 and maintain our 2026 annual EPS projection at $1.36. We also introduce our initial 2027 EPS estimate of $1.45. For the fourth consecutive quarter, Pitney Bowes raised its quarterly cash dividend, to $0.09 per share (was $0.08) and increased its share buyback program by $100 million to $500 million. Our $17 price target is now based on 12x our new 2027 EPS estimate of $1.45. Previously, we valued PBI at about 13x our 2026 EPS estimate of $1.36. Our moderate risk rating factors in PBI's healthy earnings profile, ample free cash flow and increasing dividends.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

3Q:25 EPS Just Shy Of Our Forecast; Fine-Tuned EPS Estimates Still Imply Additional Gains As Management Looks To Further Reduce Costs; Dividend Raised Again; Maintain $17 Price Target


Pitney Bowes (PBI:NYSE) | 0 0 0.0%


  • Published: 30 Oct 2025
  • Author: Anthony C. Lebiedzinski
  • Pages: 10
  • Sidoti & Company


Mainly reflecting lower than anticipated sales in its Presort Services segment, PBI delivered total revenue of $459.7 million in 3Q:25, which trailed our forecast of $467.4 million. With a lower than expected EBIT, partly offset by share buybacks, EPS of $0.31 in 3Q:25 was a penny below our forecast. PBI now expects to be at the lower end of its previous forecast for revenue and EBIT and around the midpoint of its previous guidance for EPS in 2025. As we fine tune our quarterly assumptions, we trim our 2025 EPS estimate by $0.01 to $1.29 and maintain our 2026 annual EPS projection at $1.36. We also introduce our initial 2027 EPS estimate of $1.45. For the fourth consecutive quarter, Pitney Bowes raised its quarterly cash dividend, to $0.09 per share (was $0.08) and increased its share buyback program by $100 million to $500 million. Our $17 price target is now based on 12x our new 2027 EPS estimate of $1.45. Previously, we valued PBI at about 13x our 2026 EPS estimate of $1.36. Our moderate risk rating factors in PBI's healthy earnings profile, ample free cash flow and increasing dividends.

More Content

More Content

2026 Outlook: Expect Operating Cost Reductions, Lower Interest Expense, Share Repurchases To Be Main Catalysts For Further EPS Gains; Maintain $17 Price Target

Companies: Pitney Bowes

Sidoti & Company

Expect Much Improved 2Q:25 Results As PBI Benefits From Its Streamlined Business Model, New Management; Project Further EPS Gains, Ample Free Cash Flow; Maintain $17 Price Target

Companies: Pitney Bowes

Sidoti & Company

Improved Margins And Lower Interest Expense Were Likely The Main Catalysts For Higher EPS In 3Q:25; Maintain $17 Price Target Based On Expected Further EPS Gains, Solid Cash Flow

Companies: Pitney Bowes

Sidoti & Company

Regard Recent Management Changes At PBI As A Positive Development That Should Help Drive Profitability Improvements And Shareholder Returns; Maintain $17 Price Target

Companies: Pitney Bowes

Sidoti & Company

Modestly Increase EPS Estimates After PBI Completes Convertible Senior Note Offering And Repurchases Shares; Maintain $17 Price Target

Companies: Pitney Bowes

Sidoti & Company
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In